#39
Alpha Score 94.9
TheLAPurchaser
L/S Equity trader
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
Long
May 07
$27.74
-12.8%
Buy WRBY for direct exposure to the AI wearables theme, with a near-term catalyst from Google I/O next week and a clear product roadmap in 2H, supported by mass-market retail partnership.
Buy WRBY for direct exposure to the AI wearables theme, with a near-term catalyst from Google I/O next week and a clear product roadmap in 2H, supported by mass-market retail partnership.
Consumer
Long
Mar 16
$441.00
+141.4%
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
AI/Semi
Long
Mar 11
$651.99
+164.0%
The user anticipates significant growth in SanDisk's run rate earnings per share.
AI/Semi
Long
Apr 21
$0.38
-51.6%
Long DIM.FP due to strong order growth in bioprocessing equipment (>30% in Q1), indicating a sustained recovery and acceleration in the bioprocessing thematic.
Long DIM.FP due to strong order growth in bioprocessing equipment (>30% in Q1), indicating a sustained recovery and acceleration in the bioprocessing thematic.
Healthcare
Long
Mar 16
$182.98
+21.8%
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
AI/Semi
Long
Mar 14
$191.39
-8.0%
The tweet implies positive growth prospects for the bioprocessing sector.
Healthcare
Long
Mar 14
$115.11
+5.2%
The tweet implies positive growth prospects for the bioprocessing sector.
Healthcare
Long
Mar 14
$470.00
+2.6%
The tweet implies positive growth prospects for the bioprocessing sector.
Healthcare
Long
May 12
$518.36
+15.9%
Buy SOXX as the pain trade (short squeeze / positioning) drives semis higher near-term.
AI/Semi
Long
Apr 30
$901.21
+18.1%
Buy LLY on strong earnings beat and EPS raise, with ex-US blowouts supporting the upside despite structural concerns.
Buy LLY on strong earnings beat and EPS raise, with ex-US blowouts supporting the upside despite structural concerns.
Healthcare
Long
Apr 28
$1038.99
+20.5%
Buy FICO on oversold conditions with management signaling stock too cheap sub-$1200 and an annualized buyback rate of 10% of shares outstanding as a catalyst.
Buy FICO on oversold conditions with management signaling stock too cheap sub-$1200 and an annualized buyback rate of 10% of shares outstanding as a catalyst.
Fintech
Short
Apr 27
$220.60
+17.1%
Short RMD due to GLP-1-driven CPAP attrition, slowing growth into FY27, and no multi-product floor for a single-product medtech.
Short RMD due to GLP-1-driven CPAP attrition, slowing growth into FY27, and no multi-product floor for a single-product medtech.
Healthcare
Long
Apr 23
$116.30
+129.0%
Long SOXL or semiconductor supply chain names after Jensen Huang’s statement that NVDA needs much more capacity, signaling broad demand tailwinds.
Long SOXL or semiconductor supply chain names after Jensen Huang’s statement that NVDA needs much more capacity, signaling broad demand tailwinds.
AI/Semi
Long
Apr 22
$252.49
+1.5%
Buy AMZN because its pharmacy expansion leverages existing same-day delivery logistics and One Medical's digital script capabilities to capture consumer healthcare spend and data, starting with GLP-1 medications.
Buy AMZN because its pharmacy expansion leverages existing same-day delivery logistics and One Medical's digital script capabilities to capture consumer healthcare spend and data, starting with GLP-1 medications.
Consumer
Long
Apr 22
$451.93
-11.0%
Buy ISRG as Q1 results show strong margin expansion and record buybacks, while the stock trades at a historically low forward P/E with an AI-enabled product catalyst on the horizon.
Buy ISRG as Q1 results show strong margin expansion and record buybacks, while the stock trades at a historically low forward P/E with an AI-enabled product catalyst on the horizon.
Healthcare
Showing 15 of 21 picks · sorted by mentions
Choose a mentions count to open ticker posts.